Header Logo

Shiyoung Roh

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Telemedicine
6
2024
321
0.870
 Why?
Glaucoma, Open-Angle
6
2023
47
0.820
 Why?
Glaucoma
4
2023
59
0.730
 Why?
Intraocular Pressure
7
2023
73
0.590
 Why?
Diabetic Retinopathy
3
2024
53
0.580
 Why?
Macular Degeneration
2
2024
187
0.320
 Why?
Product Packaging
1
2008
4
0.290
 Why?
Hyphema
1
2008
3
0.290
 Why?
Eye Injuries
1
2008
14
0.290
 Why?
Diabetes Mellitus
2
2023
539
0.270
 Why?
Wounds, Nonpenetrating
1
2008
108
0.270
 Why?
Patient Portals
1
2024
49
0.220
 Why?
Visual Acuity
3
2024
125
0.210
 Why?
Geographic Atrophy
1
2024
20
0.210
 Why?
Wet Macular Degeneration
1
2023
26
0.200
 Why?
Ophthalmology
1
2022
24
0.190
 Why?
Smartphone
1
2021
69
0.160
 Why?
Dark Adaptation
1
2019
8
0.160
 Why?
Follow-Up Studies
4
2024
2457
0.110
 Why?
Humans
15
2024
63319
0.100
 Why?
Pandemics
3
2023
672
0.100
 Why?
Intravitreal Injections
2
2024
49
0.100
 Why?
Optic Nerve
2
2023
25
0.090
 Why?
Patient Compliance
2
2024
360
0.090
 Why?
Anterior Chamber
1
2008
4
0.070
 Why?
Antihypertensive Agents
2
2007
166
0.070
 Why?
Phacoemulsification
1
2007
8
0.070
 Why?
Trabeculectomy
1
2007
9
0.070
 Why?
Cataract
1
2007
53
0.070
 Why?
Prostaglandins F, Synthetic
1
2006
1
0.060
 Why?
Amides
1
2006
55
0.060
 Why?
Cross-Sectional Studies
2
2021
2571
0.050
 Why?
Lipids
1
2006
314
0.050
 Why?
Telephone
1
2023
119
0.050
 Why?
Appointments and Schedules
1
2023
60
0.050
 Why?
Ranibizumab
1
2021
20
0.050
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2021
33
0.050
 Why?
Nerve Fibers
1
2021
30
0.050
 Why?
Retinal Ganglion Cells
1
2021
30
0.040
 Why?
Bevacizumab
1
2021
59
0.040
 Why?
Female
5
2024
32812
0.040
 Why?
Diagnostic Techniques, Ophthalmological
1
2021
14
0.040
 Why?
Angiogenesis Inhibitors
1
2021
77
0.040
 Why?
Photography
1
2021
41
0.040
 Why?
Aged
4
2024
14400
0.040
 Why?
Retina
1
2021
124
0.040
 Why?
Recombinant Fusion Proteins
1
2021
489
0.040
 Why?
Retrospective Studies
2
2021
6642
0.040
 Why?
Visual Fields
1
2019
49
0.040
 Why?
Disease Progression
1
2023
1171
0.040
 Why?
Tomography, Optical Coherence
1
2021
223
0.040
 Why?
Referral and Consultation
1
2021
422
0.030
 Why?
Patient Satisfaction
1
2021
433
0.030
 Why?
Middle Aged
3
2024
17562
0.030
 Why?
Adolescent
1
2008
6247
0.030
 Why?
Prospective Studies
2
2019
3285
0.030
 Why?
Pilot Projects
1
2019
1007
0.030
 Why?
Male
4
2024
29840
0.030
 Why?
Reproducibility of Results
1
2019
1650
0.030
 Why?
Aged, 80 and over
2
2019
5449
0.030
 Why?
Risk Factors
1
2022
5345
0.020
 Why?
Surveys and Questionnaires
1
2019
2676
0.020
 Why?
Tonometry, Ocular
1
2007
20
0.020
 Why?
Lens Implantation, Intraocular
1
2007
8
0.020
 Why?
Mitomycin
1
2007
26
0.020
 Why?
Bimatoprost
1
2006
1
0.020
 Why?
Cloprostenol
1
2006
1
0.020
 Why?
Ophthalmic Solutions
1
2006
7
0.020
 Why?
Double-Blind Method
1
2006
738
0.010
 Why?
Circadian Rhythm
1
2006
382
0.010
 Why?
Adult
1
2019
16796
0.010
 Why?
Roh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_